Gregory S. Moss - Nov 9, 2021 Form 4 Insider Report for Kadmon Holdings, Inc. (KDMN)

Role
EVP, Gen. Coun. / CCO.
Signature
/s/ Gregory S. Moss
Stock symbol
KDMN
Transactions as of
Nov 9, 2021
Transactions value $
-$9,770,625
Form type
4
Date filed
11/9/2021, 04:39 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDMN Common Stock Disposed to Issuer -$168K -17.7K -100% $9.50 0 Nov 9, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDMN Stock Appreciation Right Disposed to Issuer -$363K -75K -100% $4.84 0 Nov 9, 2021 Common Stock, par value $0.001 75K $4.66 Direct F2, F3
transaction KDMN Performance Stock Option (right to buy) Disposed to Issuer -$879K -150K -100% $5.86 0 Nov 9, 2021 Common Stock, par value $0.001 150K $3.64 Direct F2, F3
transaction KDMN Stock Option (right to buy) Disposed to Issuer -$527K -75K -100% $7.03 0 Nov 9, 2021 Common Stock, par value $0.001 75K $2.47 Direct F2, F3
transaction KDMN Stock Option (right to buy) Disposed to Issuer -$2.21M -300K -100% $7.36 0 Nov 9, 2021 Common Stock, par value $0.001 300K $2.14 Direct F2, F3
transaction KDMN Stock Option (right to buy) Disposed to Issuer -$1.86M -360K -100% $5.16 0 Nov 9, 2021 Common Stock, par value $0.001 360K $4.34 Direct F2, F3
transaction KDMN Stock Option (right to buy) Disposed to Issuer -$3.77M -680K -100% $5.54 0 Nov 9, 2021 Common Stock, par value $0.001 680K $3.96 Direct F2, F3
transaction KDMN Equity Appreciation Rights Unit Disposed to Issuer -$700 -200 -100% $3.50 0 Nov 9, 2021 Common Stock, par value $0.001 200 $6.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Gregory S. Moss is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger").
F2 In connection with the Merger, all unvested stock options ("Options") and equity appreciation rights ("EARs") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option and EAR award.
F3 Represents the payment per share of Common Stock received in exchange for the cancellation of each Option and EAR.